Day One Biopharmaceuticals I

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$21.53

+0.00 (+0.00%)

Analyst Consensus

Hold

Analysts

Moderate

Coverage

Buy 0 0%

Hold 10 77%

Sell 3 23%

Price Target

Analyst Price Target +161.4% upside

Low Target $41.40

Average Target $56.28

High Target $65.73

Current Price $21.53

Current
$21.53

Target
$56.28

$41.40 $56.28 avg $65.73

Scenario Analysis

Bear Case

$41.40

92.3%

Low target

Base Case

$56.28

+161.4%

Avg target

Bull Case

$65.73

+205.3%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$21.53

0.0% from high

52-Week Low

$5.64

+282.1% from low

Target vs 52W High

$56.28

+161.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.6%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.9%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%